Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide

Antimicrobial Agents and Chemotherapy
Randal EckertWenyuan Shi


Within the repertoire of antibiotics available to a prescribing clinician, the majority affect a broad range of microorganisms, including the normal flora. The ecological disruption resulting from antibiotic treatment frequently results in secondary infections or other negative clinical consequences. To address this problem, our laboratory has recently developed a new class of pathogen-selective molecules, called specifically (or selectively) targeted antimicrobial peptides (STAMPs), based on the fusion of a species-specific targeting peptide domain with a wide-spectrum antimicrobial peptide domain. In the current study, we focused on achieving targeted killing of Streptococcus mutans, a cavity-causing bacterium that resides in a multispecies microbial community (dental plaque). In particular, we explored the possibility of utilizing a pheromone produced by S. mutans, namely, the competence stimulating peptide (CSP), as a STAMP targeting domain to mediate S. mutans-specific delivery of an antimicrobial peptide domain. We discovered that STAMPs constructed with peptides derived from CSP were potent against S. mutans grown in liquid or biofilm states but did not affect other oral streptococci tested. Further studies showed that a...Continue Reading


Dec 1, 1975·Archives of Oral Biology·A H Rogers
Sep 1, 1988·Journal of Clinical Periodontology·I D Mandel
Sep 1, 1988·Journal of Clinical Periodontology·C B Walker
Apr 1, 1987·Journal of Clinical Periodontology·P Axelsson, J Lindhe
Dec 1, 1986·Microbiological Reviews·W J Loesche
Nov 1, 1987·Journal of Bacteriology·M N GilmourR K Selander
Mar 17, 2000·Immunological Reviews·H G Boman
Feb 24, 2001·Journal of Bacteriology·Y H LiDennis G Cvitkovitch
Jul 21, 2001·Lancet·Philip S Stewart, J William Costerton
Apr 5, 2002·Clinical Microbiology Reviews·Rodney M Donlan, J William Costerton
Aug 28, 2002·International Journal of Medical Microbiology : IJMM·Philip S Stewart
Oct 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Dragana AjdićJoseph J Ferretti
May 22, 2003·Bioconjugate Chemistry·Rainer FischerRoland Brock
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ki-Jong RheeKatherine L Knight
Mar 24, 2004·Nature Reviews. Microbiology·Timothy J Mitchell
May 5, 2004·Best Practice & Research. Clinical Gastroenterology·Karen M PickardThomas T MacDonald
May 7, 2004·Journal of Clinical Gastroenterology·Kyu Y RheeCharles Maltz
May 26, 2004·Immunology Letters·Helena Tlaskalová-HogenováAlena Kokesová
Jul 31, 2004·The Journal of Nutrition·R A Rastall
Sep 18, 2004·Peptides·Josephine R Chandler, Gary M Dunny
Oct 16, 2004·Expert Review of Anti-infective Therapy·Christoph A FuxJ William Costerton
Dec 2, 2004·Nature Reviews. Immunology·Philippe J Sansonetti
Jan 6, 2005·Microbiology·Justin MerrittWenyuan Shi
Jul 13, 2005·Community Dentistry and Oral Epidemiology·David Beighton
Sep 17, 2005·FEMS Microbiology Letters·Fengxia QiSteven D Goodman
Nov 8, 2005·Journal of Clinical Microbiology·J A AasFloyd E Dewhirst
Nov 8, 2005·Journal of Clinical Microbiology·P M CorbyB J Paster
Mar 25, 2006·Proceedings. Biological Sciences·Gabriel G PerronGraham Bell
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Randal EckertWenyuan Shi


Nov 18, 2008·The Journal of Antimicrobial Chemotherapy·Kristina FlemmingTrond Flaegstad
Apr 14, 2010·Antimicrobial Agents and Chemotherapy·Peter SuciMark Young
Apr 27, 2011·Antimicrobial Agents and Chemotherapy·Christopher W KaplanRandal Eckert
Feb 14, 2007·Antimicrobial Agents and Chemotherapy·Jian HeWenyuan Shi
Mar 10, 2010·Antimicrobial Agents and Chemotherapy·Jian HeRandal Eckert
Dec 8, 2007·Microbiology and Molecular Biology Reviews : MMBR·H K KuramitsuWenyuan Shi
Jan 11, 2011·Canadian Journal of Microbiology·Guillaume G Nicolas, Marc C Lavoie
Aug 18, 2012·Advances in Dental Research·Randal EckertWenyuan Shi
Aug 28, 2009·Advances in Dental Research·R A BurneM Nascimento
Aug 28, 2009·Advances in Dental Research·Xuesong HeWenyuan Shi
Aug 23, 2011·PloS One·Daniel YarbroughWenyuan Shi
May 7, 2013·Future Microbiology·Delphine Dufour, Céline M Lévesque
Jun 24, 2008·Critical Reviews in Microbiology·Raymond Murray Dawson, Chun-Qiang Liu
Jan 29, 2011·Critical Reviews in Microbiology·Vipin Chandra Kalia, Hemant J Purohit
Nov 6, 2014·Expert Review of Anti-infective Therapy·Su-Jin KangBong-Jin Lee
Mar 17, 2010·Expert Opinion on Therapeutic Patents·Fu Chen, Dong Wang
Oct 4, 2015·FEMS Microbiology Reviews·Catherine GrandclémentDenis D Faure
Mar 19, 2011·Expert Opinion on Therapeutic Patents·Zhong-Cheng Song, Hai-Liang Zhu
Aug 19, 2007·Journal of Pharmaceutical Sciences·Lisa M RossiGeorge Y Wu
Dec 24, 2015·ACS Nano·Julie S BiteenThomas D Young
Jun 3, 2015·Proceedings of the National Academy of Sciences of the United States of America·Lihong GuoXuesong He
Jun 5, 2012·Journal of Bioscience and Bioengineering·Wataru AokiMitsuyoshi Ueda
Jul 8, 2011·International Journal of Antimicrobial Agents·Nicole K Brogden, Kim A Brogden
Feb 4, 2014·Organic Letters·Michal S HallsideAndrew J Phillips
Feb 4, 2009·International Journal of Antimicrobial Agents·Jian HeRandal Eckert
Aug 7, 2012·Chemical Biology & Drug Design·Wataru AokiMitsuyoshi Ueda
Dec 8, 2010·Periodontology 2000·Philip D MarshDeirdre A Devine
Dec 8, 2010·Periodontology 2000·Jonas A RodriguesKlaus W Neuhaus
Nov 3, 2009·Chemical Biology & Drug Design·Lina LiWenyuan Shi
Jul 29, 2015·Trends in Microbiology·Jorge Frias-Lopez
Jan 24, 2013·Peptides·Bruno Rocha da SilvaEdson Holanda Teixeira
Jul 23, 2011·Virulence·Ruijie HuangRichard L Gregory

Related Concepts

Related Feeds


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.


Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.